Rona Jeffrey A
Insider CIK 1311404 · SANW Director · GBSN Chief Financial Officer · OVID Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OVID Ovid Therapeutics Inc. | A Award deriv | 2026-02-26 | 2026-03-02 | 408,750 | — | $0 | 408,750 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award | 2026-02-26 | 2026-03-02 | 68,125 | — | $0 | 156,313 | SEC↗ |
| OVID Ovid Therapeutics Inc. | S Sale | 2026-02-23 | 2026-03-02 | 8,541 | $1.45 | $12.4K | 88,188 | SEC↗ |
| OVID Ovid Therapeutics Inc. | S Sale | 2025-02-26 | 2025-02-28 | 3,902 | $0.56 | $2.2K | 67,973 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2025-02-20 | 2025-02-24 | 262,500 | — | $0 | 262,500 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award | 2025-02-20 | 2025-02-24 | 43,750 | — | $0 | 71,875 | SEC↗ |
| SANW S&W Seed Co | A Award | 2024-12-17 | 2024-12-19 | 12,725 | — | $0 | 20,700 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2024-07-30 | 2024-08-01 | 315,000 | — | $0 | 315,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2024-02-22 | 2024-02-26 | 168,750 | — | $0 | 0 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award | 2024-02-22 | 2024-02-26 | 28,125 | — | $0 | 28,125 | SEC↗ |
| SANW S&W Seed Co | A Award | 2023-12-15 | 2023-12-19 | 151,525 | — | $0 | 151,525 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2023-02-23 | 2023-02-27 | 175,000 | — | $0 | 175,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2022-04-08 | 2022-04-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2022-04-08 | 2022-04-12 | 194,399 | — | $0 | 194,399 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2022-02-03 | 2022-02-04 | 218,750 | — | $0 | 218,750 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2021-06-02 | 2021-06-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2020-12-17 | 2020-12-21 | 175,000 | — | $0 | 175,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2020-10-11 | 2020-10-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | A Award deriv | 2020-09-30 | 2020-10-02 | 325,000 | — | $0 | 325,000 | SEC↗ |
| GBSN Great Basin Scientific, In | C Conversion deriv | 2014-10-15 | 2014-10-17 | 26,883 | — | $0 | 0 | SEC↗ |
| GBSN Great Basin Scientific, In | C Conversion deriv | 2014-10-15 | 2014-10-17 | 9,117 | — | $0 | 0 | SEC↗ |
| GBSN Great Basin Scientific, In | C Conversion | 2014-10-15 | 2014-10-17 | 9,117 | — | $0 | 9,117 | SEC↗ |
| GBSN Great Basin Scientific, In | C Conversion | 2014-10-15 | 2014-10-17 | 26,883 | — | $0 | 36,000 | SEC↗ |
| GBSN Great Basin Scientific, In | A Award deriv | 2014-10-08 | 2014-10-10 | 50,784 | — | $0 | 50,784 | SEC↗ |